Assertio Holdings Inc. (ASRT)
NASDAQ (CM) NASDAQ (CM) Primary 
Assertio (ASRT) Moves 17.0% Higher: Will This Strength Last?
Assertio (ASRT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Are Medical Stocks Lagging Assertio (ASRT) This Year?
Here is how Assertio (ASRT) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
Does Assertio (ASRT) Have the Potential to Rally 115.05% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 115.1% in Assertio (ASRT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Assertio (ASRT) Surges 17.9%: Is This an Indication of Further Gains?
Assertio (ASRT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Wall Street Analysts Predict an 182.79% Upside in Assertio (ASRT): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 182.8% in Assertio (ASRT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year?
Here is how Assertio (ASRT) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
Is Assertio (ASRT) Outperforming Other Medical Stocks This Year?
Here is how Assertio (ASRT) and Aura Biosciences, Inc. (AURA) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Assertio (ASRT) This Year?
Here is how Assertio (ASRT) and Aura Biosciences, Inc. (AURA) have performed compared to their sector so far this year.
Wall Street Analysts See a 230.56% Upside in Assertio (ASRT): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 230.6% in Assertio (ASRT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts Think Assertio (ASRT) Could Surge 249.87%: Read This Before Placing a Bet
The consensus price target hints at a 249.9% upside potential for Assertio (ASRT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year?
Here is how Assertio (ASRT) and Butterfly Network, Inc. (BFLY) have performed compared to their sector so far this year.
Assertio (ASRT) Surpasses Q3 Earnings and Revenue Estimates
Assertio (ASRT) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.08 per share. This compares to a loss of $0.03 per share a year ago.
